Promus Premier everolimus-eluting coronary stent system launches in Japan


Boston Scientific Corporation has launched the Promus Premier everolimus-eluting platinum chromium coronary stent system in Japan. This advanced drug-eluting system recently received Japan Ministry of Health, Labour and Welfare approval.

“It is my great pleasure to be able to provide the Promus Premier stent system to physicians and patients in Japan,” says Yusuke Naiki, president and representative director for Boston Scientific Japan K.K. 

The Promus Premier stent system received CE mark and US Food and Drug Administration (FDA) approvals in February and November of 2013, respectively.